期刊文献+

176例Ⅱ、Ⅲ期乳腺癌腋淋巴结转移临床病理相关因素分析 被引量:11

Related factors of axillary lymph node metastases in 176 cases of breast cancer with stage Ⅱ/Ⅲ
下载PDF
导出
摘要 目的探讨乳腺癌腋淋巴结转移的临床病理相关因素,为乳腺癌患者病情判断、选择合理手术方式及术后辅助治疗方案提供依据。方法回顾性分析经手术治疗的176例Ⅱ、Ⅲ期乳腺癌患者与腋淋巴结转移相关临床病理资料。结果影响Ⅱ、Ⅲ期乳腺癌腋淋巴结转移及转移数目的重要因素有乳腺癌的病理类型、分期、肿瘤大小、部位以及ER/PR和HER2表达状况。结论乳腺癌腋窝淋巴结转移受多种因素影响。 Objective To investigate the clinical and pathological related factors to axillary lymph node metastases (ALNMs) in breast cancer and to provide scientific basis for deciding disease condition,surgical procedure and adjuvant treatment in breast carcinoma.Methods The data related to ALNMs from 176 cases of breast cancer with stage Ⅱ/Ⅲ who were surgically treated from January 2000 to June 2004 were retrospectively.Results The important factors that were related to the ALNMs and the number of ALNMs in the stage Ⅱ/Ⅲ breast cancer were as follows:pathological types,stage of disease,tumor size and location,the expression of ER/PR and HER2 of neoplasms.Conclusion The rate and number of ALNMs in breast cancer are affected by many factors.
出处 《临床外科杂志》 2005年第5期282-284,共3页 Journal of Clinical Surgery
关键词 乳腺肿瘤 淋巴转移 多因素分析 breast neoplasms/surgery lymphatic metastasis multiple factor analysis
  • 相关文献

参考文献10

  • 1耿翠芝,吴祥德,王小玲,王桂兰,杨会钗,林梅.1 393例乳腺癌雌孕激素受体状况分析[J].中国肿瘤临床,2002,29(11):793-796. 被引量:14
  • 2罗荣城,张军一,麦国丰,马树东,季晨阳,蔡俊杰,丁彦青.乳腺癌HER-2和ER表达与生存期相关性的研究[J].临床肿瘤学杂志,2003,8(6):401-404. 被引量:16
  • 3Nuners RA,Harris LN.The HER2 extra cellular domain as a prognostic and predictive factor in breast cancer[J].Clin Breast Cancer,2002,3(2):125-135.
  • 4Jatoi I.Management of the axilla in primary breast cancer[J].Surg Clin North Am,1999,79(5):1061-1073.
  • 5Silverstein MJ,Skinner KA,Lomis TJ.Predicting axillary nodal positivity in 2282 patients with breast carcinoma[J].World J Surg,2001,25(6):767-772.
  • 6Manjer J,Balldin G,Garne JP.Tumour location and axillary lymph node involvement in breast cancer:a series of 3472 cases from Sweden[J].Eur J Surg Oncol,2004,30(6):610-617.
  • 7Helin HJ,Helle MJ,Kallioniemi DP,et al.Imunohistochemical determinatin of estrogen and progesterone receptors in human breast carcinoma[J].Cancer,1989,63(9):1761-1767.
  • 8Climent MA,Segui MA,Peiro G,et al.Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer.HER-2/neu effect on adjuvant tamoxifen treatment[J].Breast,2001,10(1):67-77.
  • 9Paik S,Bryant J,Park C,et al.erbB-2 and response to doxorubicin in patients with axillary lymph node-positive,hormone receptor-negative breast cancer[J].J Natl Cancer Inst,1998,90(18):1361-1370.
  • 10Korkolis D,Ardavanis A,Yotis J,et al.HER-2/neu overexpression in breast cancer:an immunohistochemical study including correlations with clinicopathologic parameters,p53 oncoprotein and cathepsin-D[J].Anticancer Res,2001,21(3C):2207-2212.

二级参考文献5

共引文献28

同被引文献89

引证文献11

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部